Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin on Endothelial Function in SLE
NCT00739050Phase 4Terminated
- Sponsor
- Organon & Co.
- Start
- Sep 2007
- Primary completion
- Feb 2008
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in cardiovascular disease (CVD) comparing Simvastatin with Placebo (2 arms). Primary endpoint: Change From Baseline in Endothelial Thickness at 12 weeks. Started Sep 2007; status: terminated.
02
Drugs
simvastatin
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT00739050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00739050.